NCT06106893View on ClinicalTrials.gov

A Clinical Study of CD19 Universal CAR-γδT Cells in Active Systemic Lupus Erythematosus

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 12, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2027

Conditions
Systemic Lupus Erythematosus
Interventions
BIOLOGICAL

CD19 Universal CAR-γδ T Cells

Intravenous infusion of CD19 Universal CAR-γδ T Cells

Trial Locations (1)

430022

RECRUITING

Wuhan Union Hospital, Wuhan

All Listed Sponsors
collaborator

Guangzhou Bio-gene Technology Co., Ltd

INDUSTRY

lead

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER